Outcome
    Moderate Evidence

    Magnesium for Melatonin Production

    Magnesium supports the enzymatic conversion of serotonin to melatonin and has RCT evidence for improving sleep quality in deficient and older adults.

    Overview

    Magnesium supports the enzymatic conversion of serotonin to melatonin and has RCT evidence for improving sleep quality in deficient and older adults.

    How It Works

    Cofactor for serotonin N-acetyltransferase in the melatonin synthesis pathway; NMDA antagonism and GABA-A agonism promote sleep onset.

    Dosing & Protocol

    Typical dose

    Recommended dose
    Glycinate or citrate, 200–400 mg, 1–2 hours before bed.
    Expected timeframe
    4-8 weeks

    Protocol

    form
    Magnesium glycinate or citrate
    duration
    8 weeks, the length of the main trial
    co factor
    Take with food, 1-2 hours before bed. The mechanism has a real biochemical basis: magnesium is a cofactor for enzymes in the pathway converting serotonin to melatonin, including N-acetyltransferase, and magnesium deficiency in animal studies reduces pineal melatonin output. In humans, the 8-week randomised trial in elderly people with insomnia that used 500 mg/day magnesium oxide reported increased serum melatonin alongside improved sleep time, efficiency and onset latency, and reduced serum cortisol - which is the most direct human evidence available. It is one trial in a specific population, melatonin was a secondary outcome, and the effect is unlikely to match taking melatonin directly. Treat this as supporting endogenous synthesis rather than replacing exogenous melatonin.
    titration
    Up to 400 mg/day in divided doses; the elderly insomnia trial used 500 mg/day of magnesium oxide
    starting dose
    200 mg elemental magnesium in the evening

    Evidence

    What the studies say

    A double-blind RCT in elderly insomniacs found magnesium (500 mg/day for 8 weeks) increased serum melatonin and improved sleep time, efficiency, and onset latency. Deficiency is common and impairs synthesis; repletion is logical and supported.

    The effect of magnesium supplementation on primary insomnia in elderly: a double-blind placebo-controlled clinical trial

    Score: 5/10
    2012n=46

    Abbasi B, Kimiagar M, Sadeghniiat K +3 more

    Higher magnesium intake was associated with better sleep quality and reduced insomnia symptoms.

    View source

    Magnesium supplementation and sleep quality in older adults: a double-blind placebo-controlled trial

    Score: 6/10
    2012
    rct
    n=46

    Abbasi B, Kimiagar M, Sadeghniiat K +3 more

    Magnesium increased serum melatonin and improved sleep efficiency versus placebo

    View source

    Safety

    Caveats

    Loose stools at higher doses; cheap oxide forms absorb poorly.

    Less likely to help if

    Well-replete individuals show smaller effects — correct deficiency first.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.